Download PDF
1 / Pages

Other users also viewed these articles

Patient-reported outcomes in RA patients treated with tofacitinib or bDMARDs in real-life conditions in two Latin American countries J.M. Reyes; M.V. Gutierrez; H. Madariaga; W. Otero; R. Guzman; J. Izquierdo; M. Abello; P. Velez; D. Castillo; D. Ponce de Leon; T. Lukic; L. Amador;
Reumatol Clin. 2023;19:319-27
Update of the Mexican College of Rheumatology guidelines for the pharmacological treatment of rheumatoid arthritis, 2018 Mario H. Cardiel; Sandra Carrillo; Marcela Pérez; Lilia Andrade; César Pacheco Tena; Luis H. Silveira; Leonardo Limón; Sergio Cerpa; Sergio Gutiérrez Ureña; Sergio Durán; Fedra Irazoque Palazuelos; Sandra Muñoz López; Sandra Araceli Sicsik Ayala; Leonor Barile; María Azucena Ramos Sánchez; Daniel Grajeda Portes; Margarita Portela; Alina Hernández Bedolla; José Luis García-Figueroa; Mauricio Montero; Carlos Abud-Mendoza; Marco Ulises Martínez Martínez; David Herrera van Ostdam; Virginia Pascual-Ramos; Javier Merayo-Chalico; Istar Guzmán-Sánchez; María Esther Pérez-Bastidas; Jorge Enrique Aguilar Arreola; Alejandra López Rodríguez; Greta Reyes-Cordero; Humberto Alfredo Ricardez; María Fernanda Hernández Cabrera; Guadalupe Olvera-Soto; Daniel Xibillé Friedmann;
Reumatol Clin. 2021;17:215-28
Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritis José María Álvaro-Gracia Álvaro; Petra Díaz del Campo Fontecha; José Luis Andréu Sánchez; Alejandro Balsa Criado; Rafael Cáliz Cáliz; Isabel Castrejón Fernández; Hèctor Corominas; José A. Gómez Puerta; Sara Manrique Arija; Natalia Mena Vázquez; Ana Ortiz García; Chamaida Plasencia Rodríguez; Lucía Silva Fernández; Jesús Tornero Molina;
Reumatol Clin. 2024;20:423-39